Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP823337.RAOisyw1A2OKoOhrgvH0U5nuo1K7UAlxPwb1DF3denhFA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP823337.RAOisyw1A2OKoOhrgvH0U5nuo1K7UAlxPwb1DF3denhFA130_assertion type Assertion NP823337.RAOisyw1A2OKoOhrgvH0U5nuo1K7UAlxPwb1DF3denhFA130_head.
- NP823337.RAOisyw1A2OKoOhrgvH0U5nuo1K7UAlxPwb1DF3denhFA130_assertion description "[In total, 82 patients with CML who had been administered 400 mg IM daily for over 6 months were genotyped for 11 single-nucleotide polymorphisms in nine genes (CYP3A4, CYP3A5, CYP2C9, CYP2C19, CYP2D6, ABCB1, SLC22A1, SLC22A2 and ABCG2) using blood samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823337.RAOisyw1A2OKoOhrgvH0U5nuo1K7UAlxPwb1DF3denhFA130_provenance.
- NP823337.RAOisyw1A2OKoOhrgvH0U5nuo1K7UAlxPwb1DF3denhFA130_assertion evidence source_evidence_literature NP823337.RAOisyw1A2OKoOhrgvH0U5nuo1K7UAlxPwb1DF3denhFA130_provenance.
- NP823337.RAOisyw1A2OKoOhrgvH0U5nuo1K7UAlxPwb1DF3denhFA130_assertion SIO_000772 23117072 NP823337.RAOisyw1A2OKoOhrgvH0U5nuo1K7UAlxPwb1DF3denhFA130_provenance.
- NP823337.RAOisyw1A2OKoOhrgvH0U5nuo1K7UAlxPwb1DF3denhFA130_assertion wasDerivedFrom befree-20150227 NP823337.RAOisyw1A2OKoOhrgvH0U5nuo1K7UAlxPwb1DF3denhFA130_provenance.
- NP823337.RAOisyw1A2OKoOhrgvH0U5nuo1K7UAlxPwb1DF3denhFA130_assertion wasGeneratedBy ECO_0000203 NP823337.RAOisyw1A2OKoOhrgvH0U5nuo1K7UAlxPwb1DF3denhFA130_provenance.